Cross-talk between PPARγ, NF-κB, and p38 MAPK signaling mediates the ameliorating effects of bergenin against the iron overload-induced hepatotoxicity
Author:
Funder
Taif University
Publisher
Elsevier BV
Subject
Toxicology,General Medicine
Reference54 articles.
1. Iron metabolism;Conway;Anaesth. Intensive Care Med.,2022
2. Iron overload in human disease;Fleming;N. Engl. J. Med.,2012
3. Galangin mitigates iron overload-triggered liver injury: up-regulation of PPARgamma and Nrf2 signaling, and abrogation of the inflammatory responses;Salama;Life Sci.,2021
4. Upregulation of Nrf2 signaling and suppression of ferroptosis and NF-κB pathway by leonurine attenuate iron overload-induced hepatotoxicity;Salama;Chem. Biol. Interact.,2022
5. Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis;Nairz;Wien Klin. Wochenschr.,2006
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A novel long non-coding RNA linc-93.2 participates in bisphenol induced oxidative stress and macrophage polarization in red common carp (Cyprinus carpio);Fish & Shellfish Immunology;2024-08
2. Oridonin Attenuates Diabetes‑induced Renal Fibrosis via the Inhibition of TXNIP/NLRP3 and NF‑κB Pathways by Activating PPARγ in Rats;Experimental and Clinical Endocrinology & Diabetes;2024-05-08
3. Targeting SIRT1, NLRP3 inflammasome, and Nrf2 signaling with chrysin alleviates the iron-triggered hepatotoxicity in rats;Toxicology;2024-05
4. Modulating SIRT1, Nrf2, and NF-κB signaling pathways by bergenin ameliorates the cadmium-induced nephrotoxicity in rats;Chemico-Biological Interactions;2024-01
5. Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases;Journal of Ethnopharmacology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3